Dernières publications scientifiques

  • Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis.

  • Auteurs Van Melkebeke L, Boesch M, Ostyn T, Huang W, Akkaya C, van Sligtenhorst M, El Abyad D, Safaeifard F, Dumarey A, Wallays M, Boeckx B, Feio-Azevedo R, Smets L, Gustot T, Trepo E, Moreno C, Putignano A, Lasser L, Colle I, Deltenre P, Marot A, Topal B, Claus E, Bonne L, Maleux G, Scheele C, Hendrikx T, Nevens F, Korf H, Roskams T, Denadai-Souza A, Lambrechts D, Govaere O, Van der Merwe S, Verbeek J
  • Revue J Hepatol
  • Date de publication 2026-04
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis.
  • Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

  • Auteurs Fischler R, Lecoq AL, Houillier P, Verdoux M, Vantyghem MC, Briot K, Besson FL, Pierquet-Ghazzar N, Beron A, Viengchareun S, Trabado S, Lecoeuvre A, Bordet C, Goujard C, Salenave S, Leboulleux S, Carreira E, Chabrolle C, Corvilain B, Chanson P, Young J, Linglart A, Grimon G, Kamenický P
  • Revue Eur J Endocrinol
  • Date de publication 2026-04
Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.
  • Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.

  • Auteurs Curigliano G, O'Shaughnessy J, Bidard FC, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, Carey LA, Okera M, Melo E, Zagouri F, Magallanes-Maciel M, Karadurmus N, Bahadur S, Speck RM, Wang XA, Pradhan K, Macey J, Kitchen H, Fairhurst S, Miller J, Jhaveri KL, Harbeck N
  • Revue ESMO Open
  • Date de publication 2026-04
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola